Excretion balance, pharmacokinetics, and metabolism following of [14C]-venglustat administration in healthy male subjects

Trial Identifier: BEX13673
Sponsor: Genzyme, a Sanofi Company
Start Date: May 2020
Primary Completion Date: June 2020
Study Completion Date: June 2020
Condition: Healthy Volunteers; Metabolic Disorder

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United Kingdom, Nottinghamshire Nottingham, Nottinghamshire, United Kingdom, NG11 6JS